Sun Pharma Advanced Research Company informs about outcome of board meeting

05 Aug 2024 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), Sun Pharma Advanced Research Company has informed that the Board of Directors of the Company at its meeting held today on August 05, 2024, have considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the first quarter ended June 30, 2024. Pursuant to Regulation 30 and 33 of the Listing Regulations, it has enclosed the Unaudited Standalone and Consolidated Financial Results of the Company, for the first quarter ended June 30, 2024 along with the Limited Review Report, issued by the Statutory Auditors of the Company. The Unaudited Standalone and Consolidated Financial Results is also being uploaded on the Company’s website https://sparc.life/ The meeting of the Board of Directors of the Company commenced at 11:30 am (IST) and concluded 02:00 pm (IST).

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

190.40 -5.70 (-2.91%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 847.55
Sagility India 28.27
AGS Transact Tech 79.58
Just Dial 1050.60
Krystal Integrated 638.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.